Cuál es el precio por Medtronic plc (2M6)

Precio por Medtronic plc (2M6) es de$88.89

Cuál es la capitalización de mercado por Medtronic plc (2M6)

Capitalización de mercado por Medtronic plc (2M6) es $114.13B

Medtronic plc (2M6) Historial de Precios

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Año	Rendimiento
2026 (TTM)	-7.17%
2025	20.52%
2024	2.12%
2023	4.10%
2022	-26.78%
2021	-6.53%
2020	1.19%
2019	20.11%
2018	14.50%
2017	13.06%
2016	-6.44%
2015	5.02%
2014	29.38%
2013	34.89%
2012	16.41%
2011	0.98%
2010	-17.35%
2009	40.68%
2008	-38.23%
2007	0.00%

Año

Rendimiento

2026 (TTM)

-7.17%

2025

20.52%

2024

2.12%

2023

4.10%

2022

-26.78%

2021

-6.53%

2020

1.19%

2019

20.11%

2018

14.50%

2017

13.06%

2016

-6.44%

2015

5.02%

2014

29.38%

2013

34.89%

2012

16.41%

2011

0.98%

2010

-17.35%

2009

40.68%

2008

-38.23%

2007

0.00%

Empresa	Precio de la acción	Cambio 1a%	País
Abbott Laboratories ABT.US	$105.56	-16.45%	US
Stryker Corporation SYK.US	$335.67	-9.55%	US
Medtronic MDT.US	$86.16	-4.62%	IE
Boston Scientific Corporation BSX.US	$69.48	-31.00%	US
Siemens Healthineers AG SMMNY.US	$20.91	-25.11%	DE

Empresa

Precio de la acción

Cambio 1a%

País